Wedelolactone, a Naturally Occurring Coumestan, Enhances Interferon-γ Signaling through Inhibiting STAT1 Protein Dephosphorylation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Wedelolactone, a Naturally Occurring Coumestan, Enhances Interferon-γ Signaling through Inhibiting STAT1 Protein Dephosphorylation
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 20, Pages 14417-14427
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-04-12
DOI
10.1074/jbc.m112.442970
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of topoisomerase IIα: Novel function of wedelolactone
- (2011) Petr Benes et al. CANCER LETTERS
- Negative regulation of interferon-γ/STAT1 signaling through cell adhesion and cell density-dependent STAT1 dephosphorylation
- (2011) Zhimin Chen et al. CELLULAR SIGNALLING
- Regulation of hepatocyte fate by interferon-γ
- (2011) Christopher J. Horras et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Development and characterization of phyto-vesicles of wedelolactone for hepatoprotective activity
- (2011) Kirti Upadhyay et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations
- (2010) A Pardanani et al. LEUKEMIA
- IFN Restores Breast Cancer Sensitivity to Fulvestrant by Regulating STAT1, IFN Regulatory Factor 1, NF- B, BCL2 Family Members, and Signaling to Caspase-Dependent Apoptosis
- (2010) Y. Ning et al. MOLECULAR CANCER THERAPEUTICS
- Treating inflammation with the Janus Kinase inhibitor CP-690,550
- (2010) Lalitha Vijayakrishnan et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Clinical Use of Interferon-γ
- (2009) Catriona H.T. Miller et al. Annals of the New York Academy of Sciences
- Inhibition of Snake Venoms and Phospholipases A2by Extracts from Native and Genetically ModifiedEclipta alba: Isolation of Active Coumestans
- (2009) Luciana C. Diogo et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- 17-Hydroxy-jolkinolide B Inhibits Signal Transducers and Activators of Transcription 3 Signaling by Covalently Cross-Linking Janus Kinases and Induces Apoptosis of Human Cancer Cells
- (2009) Y. Wang et al. CANCER RESEARCH
- Herbal Extract of Wedelia chinensis Attenuates Androgen Receptor Activity and Orthotopic Growth of Prostate Cancer in Nude Mice
- (2009) C.-H. Tsai et al. CLINICAL CANCER RESEARCH
- Drug Discovery and Protein Tyrosine Phosphatases
- (2009) Mark Blaskovich CURRENT MEDICINAL CHEMISTRY
- Acquisition of a Potent and Selective TC-PTP Inhibitor via a Stepwise Fluorophore-Tagged Combinatorial Synthesis and Screening Strategy
- (2009) Sheng Zhang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Pharmacologic inhibitors of I B kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo
- (2009) A. I. Idris et al. MOLECULAR CANCER THERAPEUTICS
- INHIBITION OF NFκB REDUCES CELLULAR VIABILITY IN GH3 PITUITARY ADENOMA CELLS
- (2009) John R. Vender et al. NEUROSURGERY
- The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling
- (2008) E. Mattila et al. JOURNAL OF CELL SCIENCE
- Nuclear β-Arrestin1 Functions as a Scaffold for the Dephosphorylation of STAT1 and Moderates the Antiviral Activity of IFN-γ
- (2008) Wei Mo et al. MOLECULAR CELL
- Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors
- (2008) N. Kaushik-Basu et al. NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started